Literature DB >> 1449132

Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori.

N Chiba1, B V Rao, J W Rademaker, R H Hunt.   

Abstract

Despite numerous Helicobacter pylori treatment studies, the optimum regimen(s) for its eradication remain unclear. Our objective was to determine systematically which regimen(s) gave the best pooled eradication rates, by using meta-analysis methodology. A total of 27 studies were identified. Pooled eradication rates for single (18.6%), double (48.2%), and triple therapy (82.3%) were statistically highly different (p < 0.0005). Eradication rates with amoxicillin (23.0%) and bismuth compounds (19.6%) were equivalent. Combined treatment with bismuth+metronidazole was better than bismuth+amoxicillin (55.1% vs. 43.7%, p = 0.049). Triple therapy with bismuth+metronidazole+tetracycline gave a statistically higher eradication rate (94.1%) than bismuth+metronidazole+amoxicillin (73.1%, p < 0.0005). Despite increased side effects with multiple antibiotic regimens, patients tolerated these well, without significant drop-out. The combination of bismuth, metronidazole, and tetracycline gives the best eradication rate, but the optimal doses and duration of treatment have yet to be determined. Further studies are necessary to explore factors such as antibiotic resistance and drug compliance as important factors affecting antibiotic efficacy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1449132

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  59 in total

1.  Treatment of Helicobactor pylori infection: analysis of Chinese clinical trials.

Authors:  Yu-Yuan Li; Wei-Hong Sha
Journal:  World J Gastroenterol       Date:  2000-06       Impact factor: 5.742

2.  Multidrug therapy and evolution of antibiotic resistance: when order matters.

Authors:  Gabriel G Perron; Sergey Kryazhimskiy; Daniel P Rice; Angus Buckling
Journal:  Appl Environ Microbiol       Date:  2012-06-22       Impact factor: 4.792

Review 3.  Helicobacter pylori eradication in patients with non-ulcer dyspepsia.

Authors:  H H Xia; N J Talley
Journal:  Drugs       Date:  1999-11       Impact factor: 9.546

4.  H pylori infection.

Authors:  P S Phull; M R Jacyna
Journal:  Br J Gen Pract       Date:  1996-01       Impact factor: 5.386

5.  Influence of a proton pump inhibitor-based therapy on Helicobacter pylori strain selection.

Authors:  S L Hazell; H M Mitchell; G Hanna; G Daskalopoulos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-07       Impact factor: 3.267

6.  The relationship between periodontal disease attributes and Helicobacter pylori infection among adults in the United States.

Authors:  Bruce A Dye; Deanna Kruszon-Moran; Geraldine McQuillan
Journal:  Am J Public Health       Date:  2002-11       Impact factor: 9.308

Review 7.  Role of Helicobacter pylori in gastrointestinal disease: implications for primary care of a revolution in management of dyspepsia.

Authors:  B C Delaney
Journal:  Br J Gen Pract       Date:  1995-09       Impact factor: 5.386

8.  Helicobacter pylori and upper gastrointestinal disease: a survey of gastroenterologists in the United Kingdom.

Authors:  R Milne; R P Logan; D Harwood; J J Misiewicz; D Forman
Journal:  Gut       Date:  1995-09       Impact factor: 23.059

9.  High Helicobacter pylori numbers are associated with low eradication rate after triple therapy.

Authors:  M Moshkowitz; F M Konikoff; Y Peled; M Santo; A Hallak; Y Bujanover; E Tiomny; T Gilat
Journal:  Gut       Date:  1995-06       Impact factor: 23.059

10.  The impact of bismuth addition to sequential treatment on Helicobacter pylori eradication: A pilot study.

Authors:  Sebahat Basyigit; Ayse Kefeli; Ferdane Sapmaz; Abdullah Ozgür Yeniova; Zeliha Asilturk; Murat Hokkaomeroglu; Metin Uzman; Yasar Nazligul
Journal:  Bosn J Basic Med Sci       Date:  2015-10-25       Impact factor: 3.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.